Biochips: DNA Biochips, Protein Biochips, Lab-on-a-Chip

Biochips - Global Strategic Business Report

Global Industry Analysts, Date of Publication: Mar 23, 2016, 292 Pages
US$4,950.00
GIA-MCP1026

Biochips: DNA Biochips, Protein Biochips, Lab-on-a-Chip

This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others. The report further analyzes the market by the following Applications: Research, Diagnostics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -

Affymetrix, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Cepheid Inc.
Fluidigm Corporation
 

Biochips - Global Strategic Business Report
TABLE OF CONTENTS

 I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

      Study Reliability and Reporting Limitations                       I-1
      Disclaimers                                                       I-2
      Data Interpretation & Reporting Level                             I-2
       Quantitative Techniques & Analytics                              I-3
      Product Definitions and Scope of Study                            I-3
       A. DNA Biochips                                                  I-3
       B. Protein Biochips                                              I-3
       C. Lab-on-a-Chip                                                 I-4
       D. Others                                                        I-4


 II. EXECUTIVE SUMMARY

  1. INDUSTRY OVERVIEW                                                  II-1
      Biochips - A Primer                                               II-1
      Expanding Application Areas                                       II-1
      Current & Future Analysis                                         II-2
       DNA Biochips Lead the Application Front                          II-3
       Protein Biochips - Set for Robust Expansion                      II-3
       Lab-on-a-Chip: Fusion of Nanotechnology & Genetic Engineering    II-4
      Key Applications of Lab-on-a-Chip Technology                      II-4
       Molecular Biology and Lab-On-A-Chip                              II-4
       Proteomics and Lab-On-A-Chip                                     II-5
       Cell Biology and Lab-On-A-Chip                                   II-5
       Chemistry and Lab-On-A-Chip                                      II-5
      Growth Drivers/Market Trends                                      II-5
       Proteomics and Genomics Drive Demand for Biochips                II-6
       Growing Preference for DNA/Protein Biochips in Personalized
        Medicine                                                        II-6
       Application of Biochips in Drug Discovery - A Strong Growth
        Driver                                                          II-7
       Cancer: An Important Driver for the Biochips Market              II-7
        Table 1: World Cancer Incidence by Geographic Region and
        Gender (2012): Number of New Cancer Cases Reported (in
        Thousands) for Asia-Oceania, Europe, North America, Latin
        America & The Caribbean, and Africa (includes corresponding
        Graph/Chart)                                                    II-8

        Table 2: Global Incidence of Common Cancers in Men (2012):
        Number of New Cases Reported in Thousands for Lung &
        Bronchus, Prostate, Colorectal, and Liver Cancers (includes
        corresponding Graph/Chart)                                      II-9

        Table 3: Global Incidence of Common Cancers in Women (2012):
        Number of New Cases Reported in Thousands for Breast,
        Colorectal, Lung & Bronchus, and Liver Cancers (includes
        corresponding Graph/Chart)                                      II-9
       Increasing Prevalence of Lifestyle Diseases Boost Diagnostic
        Microarray Market                                               II-10
        Table 4: Global Diabetes Mellitus Incidence among Ages 20-79
        (2014E & 2035P): Prevalence (in Millions) and Percentage
        Share by Geographic Region (includes corresponding
        Graph/Chart)                                                    II-10

        Table 5: Percentage Increase in DM Incidence among Ages
        20-79 Worldwide by Geographic Region: 2013-2035 (includes
        corresponding Graph/Chart)                                      II-11
       Government Efforts to Promote Biochip Technology                 II-11
       Integrating Tools with Diagnostic Capabilities with
        Smartphones - A Futuristic Trend                                II-12
       Microfluidic and Lab-on-a-chip Devices for Pharmacogenomics      II-13
       Lab-on-a-Chip System for Better Pulmonary Disease Outcome        II-13
      Industry Challenges                                               II-14
       Standardization: A Key Challenge                                 II-14
       High Costs Restrain Growth                                       II-15
       Precise Protein Detection: A Challenge                           II-15

  2. INNOVATIONS IN THE BIOCHIPS INDUSTRY                               II-16
      Biochip Innovations in Drug Discovery Applications                II-18
       HuRELflow                                                        II-18
       MetaChip and Subsequent Versions                                 II-18
       Lab-on-a-Chip Devices in Smart Delivery of Drugs                 II-19
      Biochips from AYOXXA: A Giant Leap in Protein Multiplexing        II-19
      Key Developments in the Past                                      II-20

  3. COMPETITION                                                        II-22
      Industry Structure                                                II-22
      Major Participants                                                II-22
       Affymetrix: A Pioneer Player                                     II-22
      Growing Partnerships between Pharma and Biotech Companies         II-22
      Outsourcing: A Positive Trend                                     II-23

  4. PRODUCT OVERVIEW                                                   II-24
      Biochips - Complex Blend of Biochemistry and Electronics          II-24
      Historical Perspective                                            II-24
      Promising Biochips Promote Biological Research                    II-25
      Lab-on-a-chip: An Enabled Technology                              II-26
      Utility                                                           II-26
      Evolution and Segmentation                                        II-27
      Differing Perspectives                                            II-27
      Classification of Biochips                                        II-27
      Need for Biochips                                                 II-28
       Manufacturing Systems Used in Biochip Manufacture                II-29
      Working of a Biochip                                              II-29
       DNA Transcription & Translation through A Biochip                II-29
      A Functional Model                                                II-30
      Cocktail of Disparate Technically Specialized Applications        II-30
       Biochips: By-product of Multi-disciplinary Sciences              II-30
       Nanotechnology                                                   II-30
       BioMEMS                                                          II-30
       Microfluidics                                                    II-31
       Micro Total Analysis System                                      II-32

  5. BIOCHIP AND MICROARRAY CONSTRUCTION                                II-33
      Chip Architecture                                                 II-33
       Essence of a Biochip                                             II-33
       Concept of a Microarray                                          II-33
       Microarray Modules                                               II-33
      High Degree of Automation Spurs Biochips Use                      II-34
       Microfabrication Technology in Biochips made from Polymer and
        Plastics                                                        II-34
       Micro-optics in Biochips                                         II-34
       Liquid Handling Through Micro-Dispensers                         II-35
       Capillary Electrophoresis and Electrochemical Detectors          II-35
      Other Technologies                                                II-35
       Management of Bio-information                                    II-35
      Scanning                                                          II-36
      Microarray Database Management                                    II-36
      Classification of DNA Chips                                       II-36
       General Description of Spotted cDNA Microarrays                  II-36
       Spotted DNA Arrays                                               II-36
       Spotted cDNA Versus Spotted Oligonucleotide Arrays               II-37
       Limitations of Conventional cDNA Microarrays                     II-37
      Protein Biochips                                                  II-37
       General Applications of Protein Biochips:                        II-38
       Challenges in the Design of a Protein Biochip                    II-38
      Limitations of Protein Chip Technology                            II-39
      Concluding Remarks for Protein Biochips                           II-40

  6. APPLICATIONS OF BIOCHIPS                                           II-41
      Biochip Uses                                                      II-41
       Pharmaceutical Investigation                                     II-42
       Medical Diagnostics                                              II-42
      Advantages of Biosensor Chip Technology                           II-43
       Forensics                                                        II-43
       Transplantation Screening                                        II-43
       Identity Testing                                                 II-43
       Water and Environmental Testing                                  II-43
       Food Industry                                                    II-43

  7. PRODUCT INTRODUCTIONS                                              II-44
      Veredus Laboratories and AVA Launch VereVet™ Lab-on-Chip
       Application                                                      II-44
      Eurofins Scientific Launches Analytical DNA Chip Technology       II-44
      Agilent Technologies Introduces Updated SurePrint Microarrays     II-44
      Agilent Technologies Launches GenetiSure Pre-Screen Microarray    II-44
      Agilent Technologies Launches Updates to SurePrint miRNA
       Microarrays                                                      II-44
      Clontech Laboratories Launches DNA SMART ChIP-Seq Kit             II-44
      PerkinElmer Launches LabChip® GX Touch Automated
       Electrophoresis Systems                                          II-45
      Cancer Genetics Launches Urogenital Cancer Array UroGenRA         II-45
      A STAR and Veredus Launch VereTrop™ Biochip                       II-45

  8. RECENT INDUSTRY ACTIVITY                                           II-46
      Sengenics Acquires Oxford Gene Technology’s Protein Array
       Technology                                                       II-46
      Immucor Acquires Sentilus                                         II-46
      SQI Diagnostics Expands Collaboration with Global
       Pharmaceutical Company                                           II-46
      Agenix Enters into Cross-Licensing Agreement with Arrayjet
       Limited                                                          II-46
      CombiMatrix and Manhattan Labs Enter into Distribution
       Partnership                                                      II-46
      Sequenom and CombiMatrix Enter Into Collaboration Agreement       II-46

  9. FOCUS ON SELECT GLOBAL PLAYERS                                     II-47
      Affymetrix, Inc. (US)                                             II-47
      Agilent Technologies, Inc. (US)                                   II-47
      Bio-Rad Laboratories, Inc. (US)                                   II-48
      Cepheid Inc. (US)                                                 II-49
      Fluidigm Corporation (US)                                         II-49
      GE Healthcare Ltd. (UK)                                           II-50
      Hoffman-La-Roche Ltd. (Switzerland)                               II-50
      Illumina, Inc. (US)                                               II-51
      Ocimum Biosolutions Ltd. (India)                                  II-51
      PerkinElmer, Inc. (US)                                            II-52
      Takara Bio, Inc. (Japan)                                          II-52
       Clontech Laboratories, Inc. (US)                                 II-53
      Thermo Fisher Scientific Inc. (US)                                II-53

  10. GLOBAL MARKET PERSPECTIVE                                         II-55
      Table 6: World Recent Past, Current & Future Analysis for
      Biochips by Geographic Region - US, Canada, Japan, Europe,
      Asia-Pacific, Latin America, and Rest of World Markets
      Independently Analyzed with Annual Sales Figures in US$
      Million for Years 2014 through 2020 (includes corresponding
      Graph/Chart)                                                      II-55

      Table 7: World Historic Review for Biochips by Geographic
      Region - US, Canada, Japan, Europe, Asia-Pacific, Latin
      America, and Rest of World Markets Independently Analyzed with
      Annual Sales Figures in US$ Million for Years 2007 through
      2013 (includes corresponding Graph/Chart)                         II-56

      Table 8: World 14-Year Perspective for Biochips by Geographic
      Region - Percentage Breakdown of Dollar Sales for US, Canada,
      Japan, Europe, Asia-Pacific, Latin America, and Rest of World
      Markets for Years 2007, 2015 & 2020 (includes corresponding
      Graph/Chart)                                                      II-57

      Table 9: World Recent Past, Current & Future Analysis for DNA
      Biochips by Geographic Region - US, Canada, Japan, Europe,
      Asia-Pacific, Latin America, and Rest of World Markets
      Independently Analyzed with Annual Sales Figures in US$
      Million for Years 2014 through 2020 (includes corresponding
      Graph/Chart)                                                      II-58

      Table 10: World Historic Review for DNA Biochips by Geographic
      Region - US, Canada, Japan, Europe, Asia-Pacific, Latin
      America, and Rest of World Markets Independently Analyzed with
      Annual Sales Figures in US$ Million for Years 2007 through
      2013 (includes corresponding Graph/Chart)                         II-59

      Table 11: World 14-Year Perspective for DNA Biochips by
      Geographic Region - Percentage Breakdown of Dollar Sales for
      US, Canada, Japan, Europe, Asia-Pacific, Latin America, and
      Rest of World Markets for Years 2007, 2015 & 2020 (includes
      corresponding Graph/Chart)                                        II-60

      Table 12: World Recent Past, Current & Future Analysis for
      Protein Biochips by Geographic Region - US, Canada, Japan,
      Europe, Asia-Pacific, Latin America, and Rest of World Markets
      Independently Analyzed with Annual Sales Figures in US$
      Million for Years 2014 through 2020 (includes corresponding
      Graph/Chart)                                                      II-61

      Table 13: World Historic Review for Protein Biochips by
      Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
      Latin America, and Rest of World Markets Independently
      Analyzed with Annual Sales Figures in US$ Million for Years
      2007 through 2013 (includes corresponding Graph/Chart)            II-62

      Table 14: World 14-Year Perspective for Protein Biochips by
      Geographic Region - Percentage Breakdown of Dollar Sales for
      US, Canada, Japan, Europe, Asia-Pacific, Latin America, and
      Rest of World Markets for Years 2007, 2015 & 2020 (includes
      corresponding Graph/Chart)                                        II-63

      Table 15: World Recent Past, Current & Future Analysis for
      Lab-on-a-Chip by Geographic Region - US, Canada, Japan,
      Europe, Asia-Pacific, Latin America, and Rest of World Markets
      Independently Analyzed with Annual Sales Figures in US$
      Million for Years 2014 through 2020 (includes corresponding
      Graph/Chart)                                                      II-64

      Table 16: World Historic Review for Lab-on-a-Chip by
      Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
      Latin America, and Rest of World Markets Independently
      Analyzed with Annual Sales Figures in US$ Million for Years
      2007 through 2013 (includes corresponding Graph/Chart)            II-65

      Table 17: World 14-Year Perspective for Lab-on-a-Chip by
      Geographic Region - Percentage Breakdown of Dollar Sales for
      US, Canada, Japan, Europe, Asia-Pacific, Latin America, and
      Rest of World Markets for Years 2007, 2015 & 2020 (includes
      corresponding Graph/Chart)                                        II-66

      Table 18: World Recent Past, Current & Future Analysis for
      Other Biochips by Geographic Region - US, Canada, Japan,
      Europe, Asia-Pacific, Latin America, and Rest of World Markets
      Independently Analyzed with Annual Sales Figures in US$
      Million for Years 2014 through 2020 (includes corresponding
      Graph/Chart)                                                      II-67

      Table 19: World Historic Review for Other Biochips by
      Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
      Latin America, and Rest of World Markets Independently
      Analyzed with Annual Sales Figures in US$ Million for Years
      2007 through 2013 (includes corresponding Graph/Chart)            II-68

      Table 20: World 14-Year Perspective for Other Biochips by
      Geographic Region - Percentage Breakdown of Dollar Sales for
      US, Canada, Japan, Europe, Asia-Pacific, Latin America, and
      Rest of World Markets for Years 2007, 2015 & 2020 (includes
      corresponding Graph/Chart)                                        II-69

      Table 21: World Recent Past, Current & Future Analysis for
      Biochips by Application - Research, Diagnostics, and Other
      Markets Independently Analyzed with Annual Sales Figures in
      US$ Million for Years 2014 through 2020 (includes
      corresponding Graph/Chart)                                        II-70

      Table 22: World Historic Review for Biochips by Application -
      Research, Diagnostics, and Other Markets Independently
      Analyzed with Annual Sales Figures in US$ Million for Years
      2007 through 2013 (includes corresponding Graph/Chart)            II-71

      Table 23: World 14-Year Perspective for Biochips by
      Application - Percentage Breakdown of Dollar Sales for
      Research, Diagnostics, and Other Markets for Years 2007, 
      2015 & 2020 (includes corresponding Graph/Chart)                  II-72


 III. MARKET

  1. THE UNITED STATES                                                  III-1
      A.Market Analysis                                                 III-1
        United States: The Global Leader for Biochips                   III-1
        Rising Demand in Biotechnology and Life Science Research
         Applications                                                   III-1
        Lab-on-a-Chip: The Leading Segment                              III-2
        Rapid Growth for Protein Biochips                               III-2
        DNA Biochip Market                                              III-3
        Growth Drivers                                                  III-3
         Demand for Personalized Medicine Drives Market for Biochips    III-3
         Aging Population: A Strong Demographic Driver                  III-3
          Table 24: North American Elderly Population by Age Group
          (1975-2050) (includes corresponding Graph/Chart)              III-4

          Table 25: The US Population Breakdown by Age Group (2014)
          (includes corresponding Graph/Chart)                          III-4
         Growing Incidence of Cancer & Lifestyle Disorders              III-5
          Opportunity Indicators: Statistics Depicting Increasing
           Incidence of Cancer and Lifestyle Disorders                  III-5
           Table 26: The US Cancer Incidence by Gender (2014): No.
           of Reported New Cases for Men and Women (includes
           corresponding Graph/Chart)                                   III-5

           Table 27: The US Cancer Incidence by Affected Site
           (2014): Number of New Cancer Cases (includes
           corresponding Graph/Chart)                                   III-6

           Table 28: Prevalence of Diabetes Mellitus in the US (2013 & 
           2035): Number of People with DM (in Thousands) in the
           20-79 Age Group for the US (includes corresponding
           Graph/Chart)                                                 III-7
        Competition                                                     III-7
        Product Introductions                                           III-7
        Strategic Corporate developments                                III-8
        Select Key Players                                              III-9
      B.Market Analytics                                                III-15
        Table 29: The US Recent Past, Current & Future Analysis for
        Biochips by Product Segment - DNA Biochips, Protein
        Biochips, Lab-on-a-Chip, and Other Markets Independently
        Analyzed with Annual Sales Figures in US$ Thousand for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-15

        Table 30: The US Historic Review for Biochips by Product
        Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and
        Other Markets Independently Analyzed with Annual Sales
        Figures in US$ Thousand for Years 2007 through 2013
        (includes corresponding Graph/Chart)                            III-16

        Table 31: The US 14-Year Perspective for Biochips by Product
        Segment - Percentage Breakdown of Dollar Sales for DNA
        Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets
        for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-17

  2. CANADA                                                             III-18
      A.Market Analysis                                                 III-18
        Current & Future Analysis                                       III-18
        Rising Incidence of Chronic Diseases Spurs Biochips Demand      III-18
         Opportunity Indicators for Biochips Market:                    III-19
          Table 32: New Cancer Cases in Canada by Gender and
          Affected Site (2012) (includes corresponding Graph/Chart)     III-19
          Table 33: New Cancer Cases in Canada by Province (2012) 
           (includes corresponding Graph/Chart)                         III-20
          Table 34: Prevalence of Diabetes Mellitus in Canada (2013 &
          2035): Number of People with DM (in Thousands) in the
          20-79 Age Group (includes corresponding Graph/Chart)          III-21
        Strategic Corporate Development                                 III-21
      B.Market Analytics                                                III-22
        Table 35: Canadian Recent Past, Current & Future Analysis
        for Biochips by Product Segment - DNA Biochips, Protein
        Biochips, Lab-on-a-Chip, and Other Markets Independently
        Analyzed with Annual Sales Figures in US$ Thousand for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-22

        Table 36: Canadian Historic Review for Biochips by Product
        Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and
        Other Markets Independently Analyzed with Annual Sales
        Figures in US$ Thousand for Years 2007 through 2013
        (includes corresponding Graph/Chart)                            III-23

        Table 37: Canadian 14-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other
        Markets for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-24

  3. JAPAN                                                              III-25
      A.Market Analysis                                                 III-25
        Elderly Population Boosts the Biochip Market                    III-25
         Table 38: Japanese Elderly (65+ Years) Population:
         2000-2020 (includes corresponding Graph/Chart)                 III-25
      B.Market Analytics                                                III-26
        Table 39: Japanese Recent Past, Current & Future Analysis
        for Biochips by Product Segment - DNA Biochips, Protein
        Biochips, Lab-on-a-Chip, and Other Markets Independently
        Analyzed with Annual Sales Figures in US$ Thousand for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-26

        Table 40: Japanese Historic Review for Biochips by Product
        Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and
        Other Markets Independently Analyzed with Annual Sales
        Figures in US$ Thousand for Years 2007 through 2013
        (includes corresponding Graph/Chart)                            III-27

        Table 41: Japanese 14-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other
        Markets for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-28

  4. EUROPE                                                             III-29
      A.Market Analysis                                                 III-29
        Current & Future Analysis                                       III-29
        Leader in the DNA Biochip Segment                               III-29
        Lab-on-chip Market in Europe                                    III-29
        European Advancements Shape Diagnostic Procedures               III-30
        Ageing Population Boosts Demand                                 III-30
         Table 42: European Country-wise Statistics of 60+
         Population as % of Total Population: 2013 (includes
         corresponding Graph/Chart)                                     III-31
        Opportunity Indicator for the Biochips Market: European
         Personalized Medicine Market Exhibits Robust Growth            III-32
        Increasing Incidence of Cancer Drives Biochips Demand           III-32
         Table 43: Cancer Incidence in Europe by Site: 2012 (in
         Thousands) (includes corresponding Graph/Chart)                III-33
      B.Market Analytics                                                III-34
        Table 44: European Recent Past, Current & Future Analysis
        for Biochips by Geographic Region - France, Germany, Italy,
        UK, Spain, Russia, and Rest of Europe Markets Independently
        Analyzed with Annual Sales Figures in US$ Thousand for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-34

        Table 45: European Historic Review for Biochips by
        Geographic Region - France, Germany, Italy, UK, Spain,
        Russia, and Rest of Europe Markets Independently Analyzed
        with Annual Sales Figures in US$ Thousand for Years 2007
        through 2013 (includes corresponding Graph/Chart)               III-35

        Table 46: European 14-Year Perspective for Biochips by
        Geographic Region - Percentage Breakdown of Dollar Sales for
        France, Germany, Italy, UK, Spain, Russia, and Rest of
        Europe Markets for Years 2007, 2015 & 2020 (includes
        corresponding Graph/Chart)                                      III-36

        Table 47: European Recent Past, Current & Future Analysis
        for Biochips by Product Segment - DNA Biochips, Protein
        Biochips, Lab-on-a-Chip, and Other Markets Independently
        Analyzed with Annual Sales Figures in US$ Thousand for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-37

        Table 48: European Historic Review for Biochips by Product
        Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and
        Other Markets Independently Analyzed with Annual Sales
        Figures in US$ Thousand for Years 2007 through 2013
        (includes corresponding Graph/Chart)                            III-38

        Table 49: European 14-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other
        Markets for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-39

  4a. FRANCE                                                            III-40
      A.Market Analysis                                                 III-40
        Current & Future Analysis                                       III-40
        Product Introduction                                            III-40
      B.Market Analytics                                                III-41
        Table 50: French Recent Past, Current & Future Analysis for
        Biochips by Product Segment - DNA Biochips, Protein
        Biochips, Lab-on-a-Chip, and Other Markets Independently
        Analyzed with Annual Sales Figures in US$ Thousand for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-41

        Table 51: French Historic Review for Biochips by Product
        Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and
        Other Markets Independently Analyzed with Annual Sales
        Figures in US$ Thousand for Years 2007 through 2013
        (includes corresponding Graph/Chart)                            III-42

        Table 52: French 14-Year Perspective for Biochips by Product
        Segment - Percentage Breakdown of Dollar Sales for DNA
        Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets
        for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-43

  4b. GERMANY                                                           III-44
      A.Market Analysis                                                 III-44
        Current & Future Analysis                                       III-44
        Berlin, Brandenburg and Biochips                                III-44
      B.Market Analytics                                                III-45
        Table 53: German Recent Past, Current & Future Analysis for
        Biochips by Product Segment - DNA Biochips, Protein
        Biochips, Lab-on-a-Chip, and Other Markets Independently
        Analyzed with Annual Sales Figures in US$ Thousand for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-45

        Table 54: German Historic Review for Biochips by Product
        Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and
        Other Markets Independently Analyzed with Annual Sales
        Figures in US$ Thousand for Years 2007 through 2013
        (includes corresponding Graph/Chart)                            III-46

        Table 55: German 14-Year Perspective for Biochips by Product
        Segment - Percentage Breakdown of Dollar Sales for DNA
        Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets
        for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-47

  4c. ITALY                                                             III-48
      A.Market Analysis                                                 III-48
        Current & Future Analysis                                       III-48
      B.Market Analytics                                                III-48
        Table 56: Italian Recent Past, Current & Future Analysis for
        Biochips by Product Segment - DNA Biochips, Protein
        Biochips, Lab-on-a-Chip, and Other Markets Independently
        Analyzed with Annual Sales Figures in US$ Thousand for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-48

        Table 57: Italian Historic Review for Biochips by Product
        Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and
        Other Markets Independently Analyzed with Annual Sales
        Figures in US$ Thousand for Years 2007 through 2013
        (includes corresponding Graph/Chart)                            III-49

        Table 58: Italian 14-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other
        Markets for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-50

  4d. THE UNITED KINGDOM                                                III-51
      A.Market Analysis                                                 III-51
        Current & Future Analysis                                       III-51
        Strategic Corporate development                                 III-51
        GE Healthcare Ltd. - A Key Player                               III-51
      B.Market Analytics                                                III-52
        Table 59: UK Recent Past, Current & Future Analysis for
        Biochips by Product Segment - DNA Biochips, Protein
        Biochips, Lab-on-a-Chip, and Other Markets Independently
        Analyzed with Annual Sales Figures in US$ Thousand for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-52

        Table 60: UK Historic Review for Biochips by Product Segment - 
        DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other
        Markets Independently Analyzed with Annual Sales Figures in
        US$ Thousand for Years 2007 through 2013 (includes
        corresponding Graph/Chart)                                      III-53

        Table 61: UK 14-Year Perspective for Biochips by Product
        Segment - Percentage Breakdown of Dollar Sales for DNA
        Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets
        for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-54

  4e. SPAIN                                                             III-55
       Market Analysis                                                  III-55
        Table 62: Spanish Recent Past, Current & Future Analysis for
        Biochips by Product Segment - DNA Biochips, Protein
        Biochips, Lab-on-a-Chip, and Other Markets Independently
        Analyzed with Annual Sales Figures in US$ Thousand for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-55

        Table 63: Spanish Historic Review for Biochips by Product
        Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and
        Other Markets Independently Analyzed with Annual Sales
        Figures in US$ Thousand for Years 2007 through 2013
        (includes corresponding Graph/Chart)                            III-56

        Table 64: Spanish 14-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other
        Markets for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-57

  4f. RUSSIA                                                            III-58
       Market Analysis                                                  III-58
        Table 65: Russian Recent Past, Current & Future Analysis for
        Biochips by Product Segment - DNA Biochips, Protein
        Biochips, Lab-on-a-Chip, and Other Markets Independently
        Analyzed with Annual Sales Figures in US$ Thousand for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-58

        Table 66: Russian Historic Review for Biochips by Product
        Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and
        Other Markets Independently Analyzed with Annual Sales
        Figures in US$ Thousand for Years 2007 through 2013
        (includes corresponding Graph/Chart)                            III-59

        Table 67: Russian 14-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other
        Markets for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-60

  4g. REST OF EUROPE                                                    III-61
       Market Analysis                                                  III-61
        Table 68: Rest of Europe Recent Past, Current & Future
        Analysis for Biochips by Product Segment - DNA Biochips,
        Protein Biochips, Lab-on-a-Chip, and Other Markets
        Independently Analyzed with Annual Sales Figures in US$
        Thousand for Years 2014 through 2020 (includes corresponding
        Graph/Chart)                                                    III-61

        Table 69: Rest of Europe Historic Review for Biochips by
        Product Segment - DNA Biochips, Protein Biochips,
        Lab-on-a-Chip, and Other Markets Independently Analyzed with
        Annual Sales Figures in US$ Thousand for Years 2007 through
        2013 (includes corresponding Graph/Chart)                       III-62

        Table 70: Rest of Europe 14-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other
        Markets for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-63

  5. ASIA-PACIFIC                                                       III-64
      A.Market Analysis                                                 III-64
        Increased Healthcare Spending Boosts the Biochips Market        III-64
        India & China Offer Significant Growth Opportunities            III-64
         Table 71: China and India Lead Global Population (July
         2013): Table Depicting China and India’s Huge Population
         Vis-a-vis Other Countries’ Population (in Million) by Age
         Group (includes corresponding Graph/Chart)                     III-65
        Rising Diabetes Incidence in Asia-Pacific Offers Significant
         Growth Opportunities                                           III-65
         Table 72: Prevalence of Diabetes Mellitus in South East
         Asia (2013 & 2035): Number of People with DM (in thousands)
         in the 20-79 Age Group for Bangladesh, Bhutan, India,
         Maldives, Mauritius, Nepal, and Sri Lanka                      III-66

         Table 73: Prevalence of Diabetes Mellitus in Western
         Asia-Pacific Regions (2013 & 2035): Number of People with
         DM (in thousands) in the 20-79 Age Group for 27 Countries
         in the Region                                                  III-67
      B.Market Analytics                                                III-68
        Table 74: Asia-Pacific Recent Past, Current & Future
        Analysis for Biochips by Geographic Region - China, and Rest
        of Asia-Pacific Markets Independently Analyzed with Annual
        Sales Figures in US$ Thousand for Years 2014 through 2020
        (includes corresponding Graph/Chart)                            III-68

        Table 75: Asia-Pacific Historic Review for Biochips by
        Geographic Region - China, and Rest of Asia-Pacific Markets
        Independently Analyzed with Annual Sales Figures in US$
        Thousand for Years 2007 through 2013 (includes corresponding
        Graph/Chart)                                                    III-69

        Table 76: Asia-Pacific 14-Year Perspective for Biochips by
        Geographic Region - Percentage Breakdown of Dollar Sales for
        China, and Rest of Asia-Pacific Markets for Years 2007, 2015 & 
        2020 (includes corresponding Graph/Chart)                       III-70

        Table 77: Asia-Pacific Recent Past, Current & Future
        Analysis for Biochips by Product Segment - DNA Biochips,
        Protein Biochips, Lab-on-a-Chip, and Other Markets
        Independently Analyzed with Annual Sales Figures in US$
        Thousand for Years 2014 through 2020 (includes corresponding
        Graph/Chart)                                                    III-71

        Table 78: Asia-Pacific Historic Review for Biochips by
        Product Segment - DNA Biochips, Protein Biochips,
        Lab-on-a-Chip, and Other Markets Independently Analyzed with
        Annual Sales Figures in US$ Thousand for Years 2007 through
        2013 (includes corresponding Graph/Chart)                       III-72

        Table 79: Asia-Pacific 14-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other
        Markets for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-73

  5a. CHINA                                                             III-74
      A.Market Analysis                                                 III-74
        Basic Environment and Commercial Development                    III-74
        Biochip Research Institutes                                     III-75
        Favorable Personalized Medicine Market Boosts Demand for
         Biochips                                                       III-75
      B.Market Analytics                                                III-76
        Table 80: Chinese Recent Past, Current & Future Analysis for
        Biochips by Product Segment - DNA Biochips, Protein
        Biochips, Lab-on-a-Chip, and Other Markets Independently
        Analyzed with Annual Sales Figures in US$ Thousand for Years
        2014 through 2020 (includes corresponding Graph/Chart)          III-76

        Table 81: Chinese Historic Review for Biochips by Product
        Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and
        Other Markets Independently Analyzed with Annual Sales
        Figures in US$ Thousand for Years 2007 through 2013
        (includes corresponding Graph/Chart)                            III-77

        Table 82: Chinese 14-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other
        Markets for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-78

  5b. REST OF ASIA-PACIFIC                                              III-79
      A.Market Analysis                                                 III-79
        India: Growing Investments in Pharmacogenomics Research
         Drives Biochips Market                                         III-79
        Product Introductions                                           III-79
        Strategic Corporate Development                                 III-80
        Ocimum Biosolutions Ltd. - A Key India-based Player             III-80
      B.Market Analytics                                                III-81
        Table 83: Rest of Asia-Pacific Recent Past, Current & Future
        Analysis for Biochips by Product Segment - DNA Biochips,
        Protein Biochips, Lab-on-a-Chip, and Other Markets
        Independently Analyzed with Annual Sales Figures in US$
        Thousand for Years 2014 through 2020 (includes corresponding
        Graph/Chart)                                                    III-81

        Table 84: Rest of Asia-Pacific Historic Review for Biochips
        by Product Segment - DNA Biochips, Protein Biochips,
        Lab-on-a-Chip, and Other Markets Independently Analyzed with
        Annual Sales Figures in US$ Thousand for Years 2007 through
        2013 (includes corresponding Graph/Chart)                       III-82

        Table 85: Rest of Asia-Pacific 14-Year Perspective for
        Biochips by Product Segment - Percentage Breakdown of Dollar
        Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and
        Other Markets for Years 2007, 2015 & 2020 (includes
        corresponding Graph/Chart)                                      III-83

  6. LATIN AMERICA                                                      III-84
       Market Analysis                                                  III-84
        Table 86: Latin American Recent Past, Current & Future
        Analysis for Biochips by Product Segment - DNA Biochips,
        Protein Biochips, Lab-on-a-Chip, and Other Markets
        Independently Analyzed with Annual Sales Figures in US$
        Thousand for Years 2014 through 2020 (includes corresponding
        Graph/Chart)                                                    III-84

        Table 87: Latin American Historic Review for Biochips by
        Product Segment - DNA Biochips, Protein Biochips,
        Lab-on-a-Chip, and Other Markets Independently Analyzed with
        Annual Sales Figures in US$ Thousand for Years 2007 through
        2013 (includes corresponding Graph/Chart)                       III-85

        Table 88: Latin American 14-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other
        Markets for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-86

  7. REST OF WORLD                                                      III-87
       Market Analysis                                                  III-87
        Table 89: Rest of World Recent Past, Current & Future
        Analysis for Biochips by Product Segment - DNA Biochips,
        Protein Biochips, Lab-on-a-Chip, and Other Markets
        Independently Analyzed with Annual Sales Figures in US$
        Thousand for Years 2014 through 2020 (includes corresponding
        Graph/Chart)                                                    III-87

        Table 90: Rest of World Historic Review for Biochips by
        Product Segment - DNA Biochips, Protein Biochips,
        Lab-on-a-Chip, and Other Markets Independently Analyzed with
        Annual Sales Figures in US$ Thousand for Years 2007 through
        2013 (includes corresponding Graph/Chart)                       III-88

        Table 91: Rest of World 14-Year Perspective for Biochips by
        Product Segment - Percentage Breakdown of Dollar Sales for
        DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other
        Markets for Years 2007, 2015 & 2020 (includes corresponding
        Graph/Chart)                                                    III-89


 IV. COMPETITIVE LANDSCAPE

     Total Companies Profiled: 79 (including Divisions/Subsidiaries - 86)

     The United States (45)
     Canada (2)
     Japan (6)
     Europe (22)
     - France (2)
     - Germany (6)
     - The United Kingdom (3)
     - Spain (2)
     - Rest of Europe (9)
     Asia-Pacific (Excluding Japan) (10)
     Middle East (1)
 
Additional Information:
This report is offered in PDF format via e-mail. Once downloaded, the PDF can’t be copied to another computer. The user is permitted to print one full copy of the report. Extra copies or licenses may be purchased at 10% of the list price.
Date of Publication:
Mar 23, 2016
File Format:
PDF via E-mail
Number of Pages:
292 Pages
Type the characters you see in the picture above.